The store will not work correctly when cookies are disabled.
1-(2-Naphthalen-2-yl-2-oxo-ethyl)-5-trifluoromethoxy-1H-indole-2,3-dione
ID: ALA84471
PubChem CID: 10363530
Max Phase: Preclinical
Molecular Formula: C21H12F3NO4
Molecular Weight: 399.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CN1C(=O)C(=O)c2cc(OC(F)(F)F)ccc21)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C21H12F3NO4/c22-21(23,24)29-15-7-8-17-16(10-15)19(27)20(28)25(17)11-18(26)14-6-5-12-3-1-2-4-13(12)9-14/h1-10H,11H2
Standard InChI Key: DEDOTKKBUCBQDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
4.9667 -7.8542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4500 -7.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1750 -6.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9542 -6.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1792 -7.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2250 -8.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0292 -5.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -8.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4250 -9.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 -8.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 -6.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2417 -9.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2750 -7.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2042 -5.7292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0292 -6.3667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6500 -10.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7417 -6.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5167 -8.1917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0042 -10.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2292 -10.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4125 -10.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3625 -5.0000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.0292 -4.7917 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7000 -5.0000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7417 -7.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4667 -10.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6417 -11.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8792 -10.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4667 -11.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 5 1 0
4 2 1 0
5 1 1 0
6 1 1 0
7 15 1 0
8 6 1 0
9 8 1 0
10 5 2 0
11 3 2 0
12 9 1 0
13 2 2 0
14 4 2 0
15 17 1 0
16 12 2 0
17 25 2 0
18 8 2 0
19 9 2 0
20 21 2 0
21 19 1 0
22 7 1 0
23 7 1 0
24 7 1 0
25 10 1 0
26 16 1 0
27 20 1 0
28 26 2 0
29 27 2 0
4 3 1 0
11 17 1 0
16 20 1 0
28 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 399.32 | Molecular Weight (Monoisotopic): 399.0718 | AlogP: 4.15 | #Rotatable Bonds: 4 |
Polar Surface Area: 63.68 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.47 | CX LogD: 4.47 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.49 | Np Likeness Score: -0.86 |
References
1. Shuttleworth SJ, Nasturica D, Gervais C, Siddiqui MA, Rando RF, Lee N.. (2000) Parallel synthesis of isatin-based serine protease inhibitors., 10 (22): [PMID:11086715] [10.1016/s0960-894x(00)00523-0] |